Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S A Halperin

Showing results (41-50 of 93) with videos related to

Pageof 10
Sort By:
Journal of Clinical Microbiology|January 1, 1990
Use of a Chinese hamster ovary cell cytotoxicity assay for the rapid diagnosis of pertussisS A Halperin, R Bortolussi, A Kasina, et al.
The Journal of Laboratory and Clinical Medicine|November 1, 1985
Enzyme-linked immunosorbent assay for identification and measurement of antibodies to group A streptococcal bacteriophageS A Halperin, E D Gray, P Ferrieri, et al.
Canadian Journal of Microbiology|December 8, 2005
Expression of diphtheria toxin in Streptococcus mutans and induction of toxin-neutralizing antiseraC W Lee, S A Halperin, A Morris, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 19, 1999
Safety and immunogenicity of Haemophilus influenzae-tetanus toxoid conjugate vaccine given separately or in combination with a three-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids and inactivated poliovirus vaccine for the first four dosesS A Halperin, J King, B Law, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|March 26, 1998
Parental willingness to enter a child in a controlled vaccine trialJ M Langley, S A Halperin, E L Mills, et al.
The Pediatric Infectious Disease Journal|September 1, 1995
Acellular pertussis vaccine as a booster dose for seventeen- to nineteen-month-old children immunized with either whole cell or acellular pertussis vaccine at two, four and six months of ageS A Halperin, E Mills, L Barreto, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 25, 2009
Safety and immunogenicity of an investigational quadrivalent meningococcal conjugate vaccine after one or two doses given to infants and toddlersS A Halperin, F Diaz-Mitoma, P Dull, et al.
Canadian Journal of Microbiology|May 16, 2006
Expression of a pertussis toxin S1 fragment by inducible promoters in oral Streptococcus and the induction of immune responses during oral colonization in miceP P Mallaley, S A Halperin, A Morris, et al.
Pediatrics|July 1, 1997
Seven days of erythromycin estolate is as effective as fourteen days for the treatment of Bordetella pertussis infectionsS A Halperin, R Bortolussi, J M Langley, et al.
The Canadian Journal of Infectious Diseases = Journal Canadien Des Maladies Infectieuses|December 27, 2007
Gemella species endocarditis in a childL K Purcell, J P Finley, R Chen, et al.
Pageof 10

Showing results (41-50 of 93) with videos related to

Sort By:
Pageof 10
Journal of Clinical Microbiology|January 1, 1990
Use of a Chinese hamster ovary cell cytotoxicity assay for the rapid diagnosis of pertussisS A Halperin, R Bortolussi, A Kasina, et al.
The Journal of Laboratory and Clinical Medicine|November 1, 1985
Enzyme-linked immunosorbent assay for identification and measurement of antibodies to group A streptococcal bacteriophageS A Halperin, E D Gray, P Ferrieri, et al.
Canadian Journal of Microbiology|December 8, 2005
Expression of diphtheria toxin in Streptococcus mutans and induction of toxin-neutralizing antiseraC W Lee, S A Halperin, A Morris, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 19, 1999
Safety and immunogenicity of Haemophilus influenzae-tetanus toxoid conjugate vaccine given separately or in combination with a three-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids and inactivated poliovirus vaccine for the first four dosesS A Halperin, J King, B Law, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|March 26, 1998
Parental willingness to enter a child in a controlled vaccine trialJ M Langley, S A Halperin, E L Mills, et al.
The Pediatric Infectious Disease Journal|September 1, 1995
Acellular pertussis vaccine as a booster dose for seventeen- to nineteen-month-old children immunized with either whole cell or acellular pertussis vaccine at two, four and six months of ageS A Halperin, E Mills, L Barreto, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 25, 2009
Safety and immunogenicity of an investigational quadrivalent meningococcal conjugate vaccine after one or two doses given to infants and toddlersS A Halperin, F Diaz-Mitoma, P Dull, et al.
Canadian Journal of Microbiology|May 16, 2006
Expression of a pertussis toxin S1 fragment by inducible promoters in oral Streptococcus and the induction of immune responses during oral colonization in miceP P Mallaley, S A Halperin, A Morris, et al.
Pediatrics|July 1, 1997
Seven days of erythromycin estolate is as effective as fourteen days for the treatment of Bordetella pertussis infectionsS A Halperin, R Bortolussi, J M Langley, et al.
The Canadian Journal of Infectious Diseases = Journal Canadien Des Maladies Infectieuses|December 27, 2007
Gemella species endocarditis in a childL K Purcell, J P Finley, R Chen, et al.
Pageof 10